https://sciex.com/content/SCIEX/na/us/en


Food Allergies – How Allergic Are You?

Jun 21, 2017 | Blogs, Food / Beverage | 0 comments

recent study published by the Annals of Allergy, Asthma, and Immunology (ACAAI), pointed out, in a study of 109 people tested, that skin prick tests are not 100 percent reliable. In the study, participants were subjected to oral food challenges prior to skin testing in which 50 percent of individuals had no reaction. It was also discovered that blood tests were not full-proof even though they measure the presence of IgE antibodies to specific foods. These results are not surprising given that 50 to 60 percent of tests result in false-positives.

This occurs for several reasons:

  • ·         Antigens are no longer present following the digestive process.
  • ·         Similar proteins amongst foods may be detected

 It would seem, therefore, that more reliable tests are needed which brings me back to the lab. Today, blood tests are commonly interpreted using Enzyme-Linked Immunosorbent Assay (ELISA) despite a high incidence of false-positives. ELISA is affordable, straightforward, and provides effective testing results when used in conjunction with a person’s medical history. However mass spectrometry is more effective in detecting allergens due to its sensitivity, ability to correspond to unique allergen peptides, and its multi-allergen capabilities. Yes, mass spec is more expensive, but because of their versatility and sensitivity, you get a swift ROI while reducing those pesky false positives. You can learn more about Mass Spectrometry Myths in one of my previous posts.

Want to learn more about mass spectrometry and food allergen testing? Visit our Allergen page or read previous blog posts.

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial